BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6755415)

  • 1. Kidney stones: current issues in diagnosis and therapy.
    Brown DC
    Postgrad Med; 1982 Dec; 72(6):124-33. PubMed ID: 6755415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers.
    Pak CY; Nicar M; Northcutt C
    Contrib Nephrol; 1982; 33():136-51. PubMed ID: 6749417
    [No Abstract]   [Full Text] [Related]  

  • 3. Etiopathogenesis, clinical manifestations, and management of canine calcium oxalate urolithiasis.
    Osborne CA; Poffenbarger EM; Klausner JS; Johnston SD; Griffith DP
    Vet Clin North Am Small Anim Pract; 1986 Jan; 16(1):133-70. PubMed ID: 3518199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic treatment of renal calcium stones. Experiences with dietary advice, cellulose, phosphate and thiazides.
    Ljunghall S; Backman U; Danielson BG; Fellström B; Johansson G; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():239-52. PubMed ID: 6938001
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental and clinical studies on calcium lithiasis. II. Prevention of recurrent calcium stones with thiazides and allopurinol].
    Okada Y; Nonomura M; Takeuchi H; Kawamura J; Yoshida O
    Hinyokika Kiyo; 1986 Sep; 32(9):1247-57. PubMed ID: 3812144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and treatment of calcium stones.
    Parks JH; Coe FL
    Semin Nephrol; 1996 Sep; 16(5):398-411. PubMed ID: 8890396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twenty-Four Hour Urine Testing and Prescriptions for Urinary Stone Disease-Related Medications in Veterans.
    Song S; Thomas IC; Ganesan C; Sohlberg EM; Chertow GM; Liao JC; Conti S; Elliott CS; Pao AC; Leppert JT
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1773-1780. PubMed ID: 31712387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of nephrolithiasis.
    Pak CY
    J Urol; 1982 Dec; 128(6):1157-64. PubMed ID: 6759686
    [No Abstract]   [Full Text] [Related]  

  • 14. Crystalluria in normal subjects and in stone formers with and without thiazide and cellulose phosphate treatment.
    Hallson PC; Rose GA
    Br J Urol; 1976; 48(7):515-24. PubMed ID: 13904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of calcium oxalate kidney stones with thiazides].
    Alon U; Better OS
    Harefuah; 1982 Apr; 102(8):338-40. PubMed ID: 7117975
    [No Abstract]   [Full Text] [Related]  

  • 16. Kidney stones. Medical management and newer options for stone 'removal'.
    Kanig SP; Conn RL
    Postgrad Med; 1985 Nov; 78(6):38-44, 47-51. PubMed ID: 4059131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney stone disease: evaluation and medical management.
    Derrick FC; Carter WC
    Postgrad Med; 1979 Oct; 66(4):115-9, 122-5. PubMed ID: 482169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is selective therapy of recurrent nephrolithiasis possible?
    Pak CY; Peters P; Hurt G; Kadesky M; Fine M; Reisman D; Splann F; Caramela C; Freeman A; Britton F; Sakhaee K; Breslau NA
    Am J Med; 1981 Oct; 71(4):615-22. PubMed ID: 7282750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathophysiology, diagnosis and conservative therapy in calcium kidney calculi].
    Hess B
    Ther Umsch; 2003 Feb; 60(2):79-87. PubMed ID: 12649986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.